Fig. 3
- ID
- ZDB-FIG-190716-28
- Publication
- Yang et al., 2019 - Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis
- Other Figures
- All Figure Page
- Back to All Figure Page
EEOD suppressed migration and invasion of high-metastatic breast cancer cell lines MDA-MB-231 and MDA-MB-453. (A–B) Wound healing assay demonstrated that EEOD treatment could remarkably decrease the healing area and migration distance of both MDA-MB-231 and MDA-MB-453 cells. The histogram (below) is the quantitative analysis of the healing area and migration distance (up). (40×). (C) Transwell assay indicated that EEOD could decrease the invasive cell number of both MDA-MB-231 and MDA-MB-453 cells. The histogram (right) is the quantitative analysis of the invasive cell number (left). (200×). (D) EEOD treatment (0–50 μg/ml) could dramatically attenuate the expression of multiple metastasis-related proteins in both MDA-MB-231 and MDA-MB-453 cells in a time-concentration dependent manner, including MMP2, MMP9, N-cadherin and vimentin. (E) EEOD at concentrations from 20 μg/ml to 40 μg/ml significantly decreased the number of disseminated tumor foci in the zebrafish body when compared with control group. *p < 0.05, **p < 0.01. |